phenylacetylglutamine has been researched along with Polyneuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, M; Chen, Q; Han, X; Jin, S; Li, Y; Lu, B; Lu, H; Tian, J; Wang, Z; Xu, J; Yan, Z | 1 |
1 other study(ies) available for phenylacetylglutamine and Polyneuropathies
| Article | Year |
|---|---|
Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Metabolomics; Polyneuropathies | 2023 |